Evaluating Cinnamon Effects on Clinical, Serologic and Sonographic Characteristics of Non-Alcoholic Fatty Liver Disease patients
- Conditions
- on-Alcoholic Fatty Liver Disease.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT2015062922977N1
- Lead Sponsor
- Deputy of Research Development Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion criteria (consenting NAFLD patients 18-65 years old; evidence of fatty liver in ultrasonography with a score of 2 or more or alanine aminotransferase (ALT) levels up to 60 U/L;) and exclusion criteria (daily alcohol consumption above 20 g in women and 30 g in men; incidence of other acute or chronic liver diseases (hepatitis B, C, etc); cirrhosis; biliary disease; known autoimmune disease; malignancy and/or inherited disorders that affect liver status (an iron storage disease, Wilson disease, etc); pregnancy and lactation; metformin consumption; incidence of hyperlipidemia or hypertension requiring medication; previous supplementation of vitamin E; usage of hepatotoxic drugs over the past 6 months prior to the trial; developing hypersensitivity to cinnamon or occurring any adverse effects; acquiring viral/autoimmune/metabolic hepatic disorders during the study; alcohol intake; withdrawing treatment or being lost to follow up clinical and para-clinical examinations)
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method